Constantine Davides
Stock Analyst at Citizens
(1.00)
# 3,900
Out of 5,124 analysts
119
Total ratings
29.09%
Success rate
-21.07%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Upgrades: Market Outperform | $30 | $21.95 | +36.67% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $34.01 | +11.75% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $2.85 | +250.88% | 12 | Jan 6, 2026 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $24 → $22 | $20.30 | +8.37% | 13 | Dec 19, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $79.45 | +53.56% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $21.99 | +40.97% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $10.89 | +120.39% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $24.30 | +97.53% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $105.88 | +41.67% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $14.57 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $7.23 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.65 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $85.58 | +32.04% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $34.92 | -25.54% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $171.27 | +44.80% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $20.12 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $8.69 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $0.88 | +496.59% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.51 | +24,266.47% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $29.11 | -48.47% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $21.80 | +3.21% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.45 | +246.94% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.81 | +1,632.24% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $1.04 | +34,515.38% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.40 | +231,328.57% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.73 | +5,417.24% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.25 | +2,339.02% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.13 | +70,696.46% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $0.15 | +3,229,471.98% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.33 | +25,657.58% | 2 | Sep 23, 2022 |
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $21.95
Upside: +36.67%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $34.01
Upside: +11.75%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $2.85
Upside: +250.88%
AMN Healthcare Services
Dec 19, 2025
Maintains: Market Outperform
Price Target: $24 → $22
Current: $20.30
Upside: +8.37%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $79.45
Upside: +53.56%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $21.99
Upside: +40.97%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $10.89
Upside: +120.39%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $24.30
Upside: +97.53%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $105.88
Upside: +41.67%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.57
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $7.23
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.65
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $85.58
Upside: +32.04%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $34.92
Upside: -25.54%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $171.27
Upside: +44.80%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $20.12
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.69
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $0.88
Upside: +496.59%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.51
Upside: +24,266.47%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $29.11
Upside: -48.47%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $21.80
Upside: +3.21%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.45
Upside: +246.94%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.81
Upside: +1,632.24%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $1.04
Upside: +34,515.38%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.40
Upside: +231,328.57%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.73
Upside: +5,417.24%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.25
Upside: +2,339.02%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.13
Upside: +70,696.46%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $0.15
Upside: +3,229,471.98%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.33
Upside: +25,657.58%